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Abstract 
 Integrated care models for substance use disorder (SUD) and reproductive health care 
have been proposed as a strategy to increase access to reproductive health care for women in 
treatment for SUD. This cross-sectional, survey-based study measured how women of 
childbearing age in residential treatment report their demand for and access to reproductive 
health care, their pregnancy intention, contraceptive utilization and preference for integrating 
reproductive health care with their current SUD treatment milieu. Eighty-five percent of the 
women interviewed (N=108) expressed a desire to prevent pregnancy in the next year, although 
only one-third (33.6%) were using a form of contraception at the time of the study. The majority 
of women (69%) reported their preference for the integration of contraceptive care and treatment 
for SUD. If cost was not an issue, 28.7% of women would prefer a long acting reversible 
contraceptive (LARC) and 40.7% would prefer either injectables, oral contraceptive pills or 
patches. Improving access to reproductive health for women in treatment for SUD by integrating 
these services may increase uptake of all methods of contraception and would be well received 
by most women. Eliciting the preferences of women related to family planning and pregnancy 
prevention and then responding to those preferences with affordable or no cost access to 
contraception is a public health imperative. These practice changes stand to improve the myriad 
health outcomes for women and children associated with unintended pregnancy in the context of 
SUD.  
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Introduction and Background 
 Substance use disorder (SUD) is defined in the Diagnostic and Statistical Manual of 
Mental Disorders, 4th edition, as a “maladaptive pattern of substance use leading to clinically 
significant impairment or distress” (American Psychiatric Association, 2013). According to the 
Substance Abuse and Mental Health Services Administration (2020), 7.2 million women aged 18 
and older had SUD in 2018. Since 2005, substance use disorders are being listed among the top 
ten major public health concerns in the United States population (Albright & Rayburn, 2009; 
Thacker et al., 2005). 
 In 2011, nearly half of the 6.1 million pregnancies in the United States were unplanned. 
However, this is the lowest rate since at least 1981 (Guttmacher Institute, 2019). This drop in the 
rate of unintended pregnancy in the general population is likely due to an overall increase in the 
use of highly effective contraceptive methods (Guttmacher Institute, 2019). Women with active 
SUD have significantly greater odds of an unintended pregnancy compared to women who do 
not have an active SUD (Terplan, Hand, Hutchinson, Salisbury-Afshar, & Heil, 2015; Than et 
al., 2005) due to the inconsistent use of reliable contraceptives (Drescher-Burke, 2014; Sharma, 
Aggarwal, & Dubey, 2002; Terplan et al., 2015). An estimated 90% of women with active SUD 
report a history of at least one unintended pregnancy (Heil et al., 2011). Rates of unintended 
pregnancy for all women correlate to inconsistent use of effective contraception, but women with 
SUD are particularly vulnerable because they often lack access to reproductive healthcare both 
when they are active in their addiction, when they enter treatment and when they are discharged 
from treatment (Bornstein, Gipson, Bleck, Sridhar, & Berger, 2018; Drescher-Burke, 2014; 
Robinowitz, Muqueeth, Scheibler, Salisbury-Afshar, & Terplan, 2016; Terplan et al., 2015). 
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 Women with SUD who become pregnant face many social and emotional hardships 
during pregnancy such as fear of criminalization, feelings of guilt and shame, and stigmatization 
from both health care professionals and society at large (Metz, Köchl, & Fischer, 2012). These 
hardships can lead to initial or exacerbation of psychiatric conditions such as post-traumatic 
stress disorder, depression or anxiety, which often underlie women’s substance abuse. In 2018, 
4.4 million women over the age of 18 had co-occurring SUD and mental illness (Substance 
Abuse and Mental Health Services Administration, 2020). Furthermore, unintended pregnancy is 
a risk for relapse among women in recovery for active SUD (ASAM, 2017; Metz et al., 2012). 
Stressors during pregnancy can cause relapse in women with SUD or an increased use of 
substances for women with untreated SUD (Metz et al., 2012). When a woman in recovery for 
active SUD relapses, the risk for morbidity and mortality increases significantly (Metz et al, 
2012).  
 Despite the increasing number of SUD treatment facilities, only 11% (2.64 million) of the 
24 million men and women with SUD receive treatment (Saia et al., 2016). Of the 2.64 million 
men and women that receive treatment for SUD, only 23% are women (Center for Behavioral 
Health Statistics and Quality, 2014). The peak age of women receiving treatment for SUD and 
peak fertility age overlap (Center for Behavioral Health Statistics and Quality, 2014). In addition 
to known barriers to treatment such as insurance coverage, treatment readiness, and inability to 
afford treatment, women report unique barriers to SUD treatment that are related to motherhood 
including limited child-care availability, increased social stigma and fear of criminal or child 
welfare consequences (Chen, Strain, Crum, & Mojtabai, 2013; Saia et al., 2016). Furthermore, 
many treatment facilities do not accept pregnant women with active SUD, which increases risk 
for overdose in the women and poses a risk for the fetus as well. 
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 Women enrolled in SUD treatment programs identified numerous barriers to reproductive 
health services, including not being asked about family planning, unable to fill prescriptions for 
birth control, difficulty making and getting to appointments, and not knowing they could discuss 
reproductive health services while in a treatment facility for substance use (Robinowitz et al., 
2016). For many women, SUD treatment facilities are the only source of medical care at the time 
of enrollment (Substance Abuse and Mental Health Services Administration, 2017). A 
systematic review by Terplan et al. (2015) concluded that offering contraception services in 
conjunction with SUD treatment could help reduce unintended pregnancy in this population. 
However, a review of literature returned only one study to date reflecting the preferences of 
women in treatment for SUD for the integration of contraception services with their current 
treatment milieu. In 2016, Terplan, Lawental, Connah, and Martin measured women’s preference 
for accessing family planning services at treatment sites including residential, intensive 
outpatient, outpatient and medication assisted treatment (MAT). This study, which conducted 
focus groups and in-depth interviews with 115 women and 95 men about their family planning 
needs, knowledge of reproductive health and preferences for integration, found that 83% of 
women and 58% of men would be more likely to use reproductive health services if they were 
offered through their SUD treatment program. 
Problem Statement 
 The benefit of women-specific SUD treatment programs include a safe environment to 
address reproductive health needs such as contraception and family planning. Several studies 
address low contraception adherence among women with SUD, however do not explore the 
preferences of women related to seeking care and reproductive intention in the context of 
recovery (Griffith, Kumaraswami, Chrysanthopoulou, Mattocks, & Clark, 2017; Robinowitz et 
NEEDS AMONG WOMEN WITH SUD 7 
al., 2016). Existing evidence suggests that co-locating SUD treatment and reproductive health 
services can benefit women by eliminating known barriers to access and increasing reproductive 
autonomy, thereby preventing unplanned pregnancies (Robinowitz et al., 2016; Terplan et al., 
2016). 
Purpose 
 The purpose of this study is to evaluate access to reproductive healthcare including 
contraception for women enrolled in treatment for SUD as well as their preferences for 
integration of family planning into treatment for SUD. Actively seeking the preferences of this 
currently underserved population will help identify and leverage opportunities for health 
promotion. Actively seeking and responding to this population’s preferences represents a move 
to support women’s reproductive autonomy while improving their access to evidence-based 
contraceptive counselling and the full range of contraceptive methods.  
Review of Evidence 
 The prevalence of substance use disorder (SUD) in the United States is high. One in 10 
people have SUD (Substance Abuse and Mental Health Services Administration, 2017); 
approximately one-third of whom are women (Griffith et al., 2017). The National Institute of 
Drug Abuse (2018) has identified the importance of gender in the course and treatment of SUD 
and the particular risk for morbidity and mortality experienced by women with untreated SUD. 
The peak age of women with SUD and peak fertility age overlap, making reliable contraception 
essential for this population. The rate of unintended or unplanned pregnancy in women with 
SUD is much higher than women without SUD (Drescher-Burke, 2014; Heil et al., 2011, 
Robinowitz et al., 2016, Smith, Morse, & Busby, 2019; Terplan et al., 2015). 
Lack of Access to Reproductive Care 
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 There are several reasons identified in the literature for why women with SUD have 
lower consistent use of reliable contraceptive methods, however poor access to reproductive care 
is frequently cited as a barrier to the consistent use of effective contraception (Black & Day, 
2016; Black, Stephens, Haber, & Lintzeris, 2012; Drescher-Burke, 2014; Griffith et al., 2017; 
Meschke, McNeely, Brown, & Prather, 2018; Robinowitz et al., 2016; Terplan et al., 2016). 
Provider bias has also been recognized as a barrier; when women with SUD attempt to access 
contraceptive services, providers tend to prioritize treatment for substance use as well as 
screening and treatment for sexually transmitted diseases (Drescher-Burke, 2014; Griffith et al., 
2017; Terplan et al., 2015). However, authors have also found that women who were screened 
and/or treated for sexually transmitted infections were also more likely to receive contraceptive 
counseling and to then elect a method of birth control (Robinowitz et al., 2016; Terplan et al., 
2016). A study by Smith, Morse and Busby (2019) found that while women in treatment for 
opioid use disorder were clear about their intention to avoid pregnancy, they also reported low 
rates of consistent birth control use, election of accessible but less effective methods of 
pregnancy prevention, alongside limited access to primary care and gynecologic services. 
 Insurance plays a vital role in access. As previously stated, women self-report lack of 
insurance coverage as a barrier to SUD treatment. Most women are eligible for Medicaid once 
they become pregnant and remain insured 60 days postpartum. As of 2017, 11% of women in 
America remain uninsured (approximately 10.6 million women) and 17% receive insurance from 
Medicaid (Kaiser Family Foundation, 2018). Those who are uninsured, active in their SUD 
without access to SUD treatment or reproductive health services are at the highest risk for poor 
health outcomes. Unfortunately, 25 states have limited scope Medicaid programs, which limits 
funds towards family planning services (Kaiser Family Foundation, 2018). From 2009 to 2012, 
NEEDS AMONG WOMEN WITH SUD 9 
48 percent of women entering substance use treatment facilities who were not pregnant were 
uninsured (Smith & Lipari, 2017). Women who are insured and/or are able to access SUD 
treatment may still lack access to reproductive health care. A focus group revealed that women 
with SUD consistently describe challenges in accessing contraception and family planning 
services, even while in treatment (Robinowitz et al., 2016).  
Patient-Centered Treatment 
 Before the 1970s, substance use treatment facilities followed a generic approach, with 
little recognition of the specific treatment needs of women (Greenfield & Grella, 2009). Many 
national institutions such as the Substance Abuse and Mental Health Services Administration 
(SAMHSA) and National Institute on Drug Abuse (NIDA) now recognize the need for women-
centered programming as a cornerstone of effective SUD treatment and recovery. Women-
centered programs focus on the treatment of SUD along with women-specific care and 
counseling for issues related to family counseling, behavioral health and reproductive health 
services (Krans et al., 2018; Robinowitz et al., 2016). Unique challenges that women face when 
enrolling into a treatment program include limited child-care availability, increased social stigma 
and fear of criminal or child welfare consequences (Chen et al., 2013; Saia et al., 2016). 
Treatment centers specific to women and their needs were established to try to increase retention 
rates for women in inpatient treatment programs (Arfken, Klein, di Menza, & Schuster, 2001). 
Integration of Reproductive Care 
 Integration of reproductive health services with SUD treatment may help decrease the 
challenges women with SUD face in accessing contraception and increase contraceptive 
utilization. A study that interviewed 115 women in SUD treatment facilities found that women 
are more proactive about family planning and planning their futures while in treatment 
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(Robinowitz et al., 2016). MacAfee, Harfmann, Kolenic and Dalton (2017) found that women 
preferred integration of reproductive services with their SUD treatment. Improving access to 
comprehensive care and access to the full range of contraceptive options increases the use of 
reliable methods (Institute of Medicine, 2004).  
Importance of Contraception 
 Consistent use of effective contraception decreases rates of unintended pregnancy 
(Guttmacher Institute, 2019). An unintended pregnancy can trigger preexisting psychological 
conditions such as anxiety and depression for women (Biaggi, Conroy, Pawlby, & Pariante, 
2016). Women are often at higher risk for relapse and overdose during prenatal and postpartum 
time because stress is a known trigger for relapse (American Society of Addiction Medicine, 
2017). Women who relapse are also at higher risk for overdose and death. Improving access to 
evidence-based contraceptive counseling and the full range of contraceptive methods increases 
reproductive autonomy by supporting women to choose how and whether to plan or prevent 
pregnancy (Upadhyay, Dworkin, Weitz, & Foster, 2014).  
 Along with personal benefits to the woman, contraception use can also delay pregnancy 
until the woman is sober and free of substances. The effects of substance exposure on neonates 
are widely known (Bornstein et al., 2018). Prenatal substance use can increase the risk of preterm 
delivery, abruptio placenta, fetal growth restriction, intrauterine fetal demise, and neonatal 
abstinence syndrome (NAS) compared with infants who were not exposed to substances 
(Bornstein et al., 2018; Stanhope, Gill, & Rose, 2013). In 2012, medical bills for all infants 
treated for NAS totaled $1.5 billion (Ko et al., 2017). Unintended pregnancies in women with 
SUD is associated with inadequate care, low birth weight and prematurity (Logan, Holcombe, 
Manlove, & Ryan, 2007). The number of women with opioid use disorder at labor and delivery 
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quadrupled from 1999 to 2014 (Haight, Ko, Tong, Bohm, & Callaghan, 2018). In order to 
decrease adverse outcomes and the incidence of high-risk pregnancies, the World Health 
Organization encourages contraceptive counseling and access to contraception for women with 
SUD (World Health Organization, 2014). 
 Integrating reproductive health care services into patient-centered SUD treatment models 
for women can alleviate reproductive health care disparities among women with SUD that result 
in myriad poor health outcomes for both women and children. Evidence-based contraceptive 
counseling empowers women with information and choice which improves health seeking 
behavior and increases reproductive autonomy by emphasizing each woman’s choice to decide if 
and when she would like to have a child. 
Theoretical Model 
 The Social Cognitive Theory (SCT) is a health behavior theory that describes a dynamic, 
ongoing process in which personal factors, environmental factors, and human behavior exert 
influence upon each other (Bandura, 1986). SCT integrates concepts from cognitive, behaviorist, 
and emotional models of behavior change, but is centered around the assumption of reciprocal 
determinism. This means that a person can be both an agent for change and a responder to 
change (Glanz, Burke, & Rimer, 2018). The three main constructs of SCT are personal factors, 
environmental factors or behavior. Within each of the three main constructs there are a number 
of concepts that help illuminate the construct and help organize variables such as behavioral 
capability, expectations, self-efficacy, observational learning (modeling), and reinforcements 
(National Institutes of Health, 2005). Behavioral capability is the knowledge and skill needed to 
perform a given behavior. Expectations are anticipated outcomes of behavior. Self-efficacy is the 
confidence in one’s ability to take action and overcome barriers.  
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 The Social Cognitive Theory is used as a theoretical framework through which to 
understand the factors predicting uptake of reproductive health care services among women in 
treatment for substance use disorder (SUD). Personal factors that influence reproductive health 
in women with SUD are reproductive intention, contraceptive preference, and preference for 
integration of contraception into SUD treatment. Environmental factors include access to health 
care and engagement in SUD treatment. Human behavior can be measured by past and current 
contraceptive utilization. The three constructs, personal factors, environmental factors and 
behavior, are continually interacting and influencing one another, a dynamic known as reciprocal 
determinism (Bandura, 1986). Personal factors are influenced by environmental factors. For 
example, cost, convenience, and access are environmental factors that influence personal factors 
such as preference of contraception, or preference to integrate contraception into SUD treatment. 
This project is examining all the factors of the SCT that influence one another continuously. See 
figure 1. 
Project Design 
 This cross-sectional survey-based study was designed to measure how women engaged in 
residential treatment report their demand for and access to reproductive health care, their 
pregnancy intention, contraceptive utilization and preference for integrating reproductive health 
care with their current SUD treatment milieu. This project was approved by the Belmont 
Institutional Review Board in October 2019 
Clinical Setting 
 The study was conducted at a women’s residential SUD treatment facility in Nashville, 
Tennessee. The facility is a non-profit, faith-based organization that treats women from the 
Southeastern United States for addiction to alcohol, opioids, and other illicit drugs. Inpatient 
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services for medical detox are available as needed. After detox, women begin the recommended 
30-day residential treatment program, which includes medication assisted treatment (MAT), drug 
and alcohol withdrawal management, behavioral health, life skills, and peer led recovery 
meetings such as alcoholics anonymous (AA) and narcotics anonymous (NA). 
 The recommended residential treatment program is 30 days and women are eligible to 
participate in treatment if they are 18 years or older, speak English, and have Medicaid or private 
health insurance. Women who are uninsured may apply for scholarship funding available 
through grants. Most commercial and government-funded insurances cover 30 days of residential 
treatment. Women who receive a grant are approved for 30 days of residential treatment as well. 
Women are eligible for treatment regardless of their current pregnancy status. The facility has a 
total of 38 client rooms along with six detox beds. At capacity, the facility can provide 
residential treatment for 76 women. While engaged in care, women live together in a community 
and receive services as smaller groups of 10-12 women. 
Project Population 
 Women aged 18 to 51 years who were admitted and receiving treatment at the facility 
between October and December 2019 were eligible to participate in the study. Women over the 
age of 51 or those who had been in-house for less than 48 hours were not eligible to participate. 
The age of 51 years was selected because it is the average age of menopause and reproductive 
services are still essential up to that age (Terplan et al., 2016). Women must have been in-house 
for at least 48 hours as this is the average amount of time needed to regain cognition after 
ingestion of any substance (Terplan et al., 2016).  
 Convenience sampling was used to recruit eligible participants. Flyers describing the 
study were posted throughout the facility and the project leader made announcements during 
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weekly medical group meetings, describing the study and inviting women to complete the 
interview-led survey. Participation was voluntary and participant responses were kept 
confidential. No personally identifying information was collected by the project leader.  
Sources of Data/Data Collection Instruments 
 The survey used for this study was created by the project leader using questions from 
multiple other survey instruments to measure demographics, access to health care, specifically 
reproductive health care, reproductive intent, contraception utilization and preference for 
integration of reproductive health services with SUD treatment. See Appendix for adapted survey 
with standardized script. 
 Section I of the survey captured age in number, ethnicity, highest level of education and 
marital status. These demographic questions were adapted from the Centers for Disease Control 
(2018) National Survey of Family Growth. 
 Section II of the survey measured access to health care. Because the survey was 
completed using Qualtrics survey software, some skip logic was used in this section. A question 
about health insurance status was asked using a “yes/no” response. If the participant selected yes, 
the next question asked about the type of health insurance. However, if the participant selected 
no, using skip logic, the question about type of health insurance was omitted. Type of health 
insurance was measured using a multiple-choice question. Another question asked where specific 
services, such as well-women exam, STD screening, and prescription or method for birth control 
were received in the past. Multiple choice options were provided to determine where specific 
services were received. These questions were adapted from a study measuring the trends in 
contraceptive services of young women in America (Frost & Lindberg, 2019). A final question in 
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this section asked participants where they would go for care if they were sick. Multiple choice 
options are presented. This question was adapted from the Guttmacher Institute (2009).  
 Section III of the survey measured contraceptive utilization. The first question in this 
section asked whether certain contraceptive methods had been used in the past year. Responses 
were “yes/no”. The next question asked whether the participant was currently on a form of birth 
control. If the participant answered yes, the next question would ask what type of birth control 
they were on; however, if the participant answered no, using skip logic that question was 
omitted. A “yes/no” question asked whether cost had been a barrier in obtaining the preferred 
choice of birth control in the past. The next multiple choice question asked how the participant 
has paid for birth control in the past year. These questions were adapted from a survey from 
Guttmacher Institute (2009) which surveyed young adults about contraception utilization. The 
remaining questions in this section used skip logic. A “yes/no” question about condom use in the 
past six months was asked. If the participant answered no to using condoms in the past 6 months, 
the section would end. However, if the participant selected yes, further questions were asked. 
Further questions included primary purpose for using condoms with options of “STD 
prevention”, “pregnancy prevention”, or “both”. The next question asked about frequency of 
condom use with multiple choice responses of “Always”, “most of the time”, or “sometimes”. 
These questions were adapted from a survey which asked about intention to have sexual 
intercourse without a condom (Duran, Ferraces, Rodriguez, Rio & Sabucedo, 2017). 
 Section IV of the survey measured reproductive intent. One multiple choice question was 
adapted to measure desire to become pregnant in the next year. The question was adapted from 
“Improving Contraception Uptake Baseline Questionnaire” (Black & Day, 2016). Using skip 
logic, pregnancy intention was not asked to those who had indicated a previous tubal ligation or 
NEEDS AMONG WOMEN WITH SUD 16 
hysterectomy. Section V of the survey measured preference for integration. Questions for this 
section were adapted from Bich, Korthuis, Thu, Dinh and Minh (2016). The original study 
measured the preference for integrating SUD treatment into existing HIV treatment plans. 
Although the variables are different for this study, the logic of integration translates well. Skip 
logic was used for these questions. The section begins with a “yes/no” question asking whether 
the participant would feel comfortable speaking about contraception at the facility where the 
study took place. If the participant answered yes, the next question would ask which provider 
they would feel most comfortable talking to (doctors, nurse practitioners, pharmacists, nurses, 
therapists, or case managers). If the participant answered no, this question was omitted. The next 
question asked whether the participant would be interested in receiving birth control upon 
discharge from the facility. If the participant answered either yes or not sure, the next question 
would ask them which method of contraception they would be interested in, which is a multiple 
choice question. If the participant answered no, the survey ends. The question about which 
method of contraception they would be interested in was added to the survey by the request of 
the facility and stakeholders.  
 The adapted survey was reviewed for content validity by the project advisor and a Doctor 
of Nursing Practice nurse practitioner who works with a similar population as the study 
population. Because the survey was adapted from various other surveys and is intended to 
provide descriptive statistics, it cannot be deemed valid or reliable. The survey was piloted with 
six non-medical clinical associates at the facility who are in recovery for SUD and completed 
residential treatment either at the facility or at a similar inpatient facility.  
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Data Collection Process/Procedures 
 The project leader used a standardized script to guide participants through the survey and 
input survey responses into a laptop computer using Qualtrics survey software. To eliminate 
barriers to participation related to response fatigue, literacy and health literacy in this population, 
the project leader read the questions aloud for each participant using the standardized script. The 
survey took approximately seven minutes to complete. The surveys were completed one at a time 
in a private room at the facility. Participation was voluntary, and no protected health information 
was collected. A letter of invitation with implied consent was presented to participants. The letter 
clearly stated that participation in the study does not promise access to any services. In order to 
thank participants for their time, a candy bar was given at the end of the survey. A resource 
packet with local health departments and information about different contraception options was 
offered to all participants. 
Data Analysis 
 Data was collected using Qualtrics survey software. Collected data was then entered into 
SPSS software for analysis. Analysis included descriptive statistics to explore demographics, 
health care access, contraception utilization, reproductive intent and preference for integration. 
Results 
 From the months of October 2019 to December 2019, there were 219 admissions into the 
residential program. A total of 108 women completed the survey (N=108). The response rate was 
49%. The median age of participants was 32 years. Three-fourths (74%) were Caucasian, and 
nearly half had completed a high school diploma or earned a GED (46.3%). Over half (54.6%) of 
the sample were single, never married. Participants’ demographic characteristics are summarized 
in Table 1. 
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Access to Care 
 Three-fourths (74.1%) of the sample had health insurance at the time of the survey. Of 
the 80 that had health insurance, 93% were covered by Medicaid or a type of government-
assistance plan. In response to the item “when you are sick, where do you go for care?”, 36 
(33.3%) women indicated care from a primary care provider (PCP), 38 (35.1%) women reported 
care from an urgent care or walk-in clinic, and 34 (31.6%) women reported having visited 
Emergency Department. For reproductive healthcare, a majority of women (63%) reported 
having visited a private doctor’s office for a well woman exam; and about half (48.1%) reported 
receiving STD screenings at a community or public health clinic such as the health department. 
However, half of the women (53.7%) reported having received a prescription or method of birth 
control from a private doctor’s office, compared to 36.1% that received this from a community 
or public health clinic. Figures 2, 3, 4, and 5 depict women’s access to health care and all data 
related to access to care are summarized in Table 2.  
Reproductive Intent and Contraception Utilization 
 Twenty women (18.5%) reported having had a tubal ligation or a hysterectomy and so 
were not asked about their reproductive intent. Of the remaining women (n=88), the majority 
(85.2%) reported not wanting to become pregnant in the next year, 6 (6.8%) wanted to become 
pregnant in the next year, 1 (1.1%) was not sure, and 6 (6.8%) reported being “okay” either way. 
All data related to reproductive intent may be found in Table 3.  
 Participants’ responses about utilization of contraceptive methods were categorized based 
on efficacy and likelihood of becoming pregnant using research adapted by the Centers of 
Disease Control (2018). Tier 1 includes the implant, and an intrauterine device (IUD). Tier 1 
methods are considered to be the most effective contraceptive method with less than one 
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pregnancy per 100 women in one year (Trussell, Aiken, Micks, & Guthrie, 2018). Of the women 
who had not had a hysterectomy or tubal ligation (n=88), 16 (18.2%) women reported having 
used tier one methods in the past year. When asked about current use, 14 (15.9%) reported using 
tier 1 methods. Tier 2 includes oral contraceptives, patches, vaginal ring, and injectables. Tier 2 
methods are moderately effective with four to seven pregnancies per 100 women in one year 
(Trussell et al., 2018). Of the women who had not had a hysterectomy or tubal ligation (n=88), 
27 (30.6%) women reported having used tier 2 methods in the past year. When asked about 
current use, 11 (12.5%) women reported use of tier 2 methods. Tier 3 includes withdrawal 
method, rhythm method, emergency contraception and condoms. Tier 3 methods are the least 
effective methods with more than 13 pregnancies per 100 women in one year (Trussell et al., 
2018). Of the women who had not had a hysterectomy or tubal ligation (n=88), 65 (73.8%) 
women reported having used tier 3 contraceptive methods in the past year. The vast majority of 
women (71.6%) of women reported that they were not using any form of contraception at the 
time of the survey. Tables 4a and 4b provide a full report of contraceptive utilization in the past 
year and utilization at the time of the survey.  
 One-fourth (25.9%) of the participants reported cost as a barrier to obtaining the birth 
control of their choice. When asked how they paid for their birth control in the last year, 42 
(38.8%, N=108) women reported Medicaid insurance coverage, and 57 (52.7%, N=108) reported 
they had not used birth control in the past year. About half of the women (n=52) reported using 
condoms in the past six months. When asked frequency of condom use, 12 (23%) reported 
always using condoms, 24 (46.2%) reported using condoms most of the time, and 16 (30.7%) 
reported using condoms sometimes. Of the 52 women who reported condom use in the past six 
months, 18 (34.6%) reported using condoms for STD prevention, five (9.6%) reported using 
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condoms for pregnancy prevention, and 29 (55.7%) reported using them for both STD 
prevention and pregnancy prevention. Table 5a and 5b summarizes how women reported paying 
for their birth control and their condom utilization.  
Preference for Integration 
 In response to the question “If we could provide you with a method of birth control of 
your choice before you leave, would you be interested?”, the majority (69.4%) said yes, and 
98.1% of women stated they would feel comfortable talking about birth control while in 
treatment for substance use disorder. When asked who they would feel most comfortable talking 
to about birth control, 54 (50%) stated nurses, 25 (23.1%) stated therapists, 25 (23.1%) stated 
nurse practitioners or doctors, and 4 (3.7%) stated case managers. All data related to preference 
for integration is summarized in Table 6. 
Discussion 
 Although 85% of participants reported a desire to avoid pregnancy in the next year, only 
one-third (33.6%) were using any form of contraception at the time of the survey. Although the 
rate of effective contraceptive use was low, preference for integration of contraception with SUD 
treatment was high. The majority of women responded with a preference to integrate access to 
contraception with their treatment for SUD and almost 70% reported that they would choose to 
initiate contraception prior to discharge from treatment if it were made available and cost were 
no obstacle. Of the women who were interested in integration of services, 14.8% indicated 
preference for an IUD, 13.9% indicated preference for an implant, 16.7% indicated preference 
for oral contraception, 22.2% indicated preference for injectables and 1.8% indicated preference 
for the patch. This finding suggests that while the preference for integration of services was 
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almost unanimous, women express preference for a variety of methods, but their responses 
suggest that removing cost as a barrier would drive the election of more effective methods. 
 While half of the women were most comfortable speaking about contraception to nurses 
at their SUD facility, the other half were most comfortable with either a therapist, case manager 
or nurse practitioner. This suggests the importance of trust and relationship in the discussion of 
family planning and that there is variability around whom a woman may feel most comfortable. 
This echoes literature that supports all staff training in contraceptive counseling as an important 
aspect of improving access; hence, it is vital that all disciplines are trained in contraceptive 
counseling. By educating and training all disciplines in a SUD treatment facility, women have an 
equal opportunity to approach a conversation about contraception with whoever they are most 
comfortable with. 
 Previous studies suggest that women with SUD have a decreased uptake of contraception 
due to lack of access to health care, specifically reproductive health care. This study found that 
only 63% of women had ever received a well-women exam at a private doctor’s office and only 
53% had ever received a prescription or method of birth control from a private doctor’s office. 
This supports existing literature on the disparities in access to reproductive healthcare 
documented in this vulnerable population which is also evidenced by their use of urgent care or 
emergency departments for care when they are sick (66%). This suggests that women with SUD 
might not receive continuous and consistent care from a provider who is aware of their 
reproductive health history and SUD diagnosis. 
 Compared to previous studies, this study found a higher uptake of long-acting reversible 
contraception (LARC) in this sample compared to women in previous studies. Previous studies 
published rates of LARC uptake among women with SUD as under 6% (Smith et al., 2019; 
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Terplan et al., 2016). However, this study shows a 13% uptake of LARCs. This percentage lags 
behind the LARC uptake in the general population at 15% but is encouraging (National Survey 
of Family Growth, 2017). The finding that 68.4% of women reported using less reliable methods 
of contraception such as withdrawal method, rhythm method, emergency contraception and 
condoms may also be experiencing cost as a barrier to more reliable methods, along with access 
to a provider, availability and education. The results show that 14 (12.9%) women came into 
treatment with an existing LARC and 31 (28.7%) reported preference for a LARC in the absence 
of cost as a barrier. This suggests that women who came into treatment with a LARC report a 
preference to continue using LARCs to prevent pregnancy. This finding may be leveraged as an 
asset in the group treatment milieu because peer influence can be a powerful tool in decision 
making when it comes to contraception selection (Smith, Morse, & Busby, 2019). 
 Of the 48% of women who reported using condoms in the past six months, only 23% of 
those reported always using condoms. Of the women who reported using condoms, 55.7% 
reported using them for pregnancy prevention and STD prevention. Not only are women 
reporting high rates of using an ineffective method to prevent pregnancy but are also using this 
ineffective method inconsistently. If women were offered the method of contraception they 
preferred, the health outcomes for women and children associated with unintended pregnancy 
could improve. 
 These findings add to the existing literature that supports integration of contraception into 
SUD treatment. Similar to previous findings, this study found that women do indeed prefer the 
integration of contraception into SUD treatment. These results show us that a majority of women 
enter treatment without any method of contraception, and if these services are not offered during 
treatment, the likelihood of women receiving contraception elsewhere once discharged is 
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unlikely. Known barriers to reproductive health care will continue to decrease contraceptive 
utilization in this population. To support and promote reproductive autonomy and women’s right 
to decide whether and how to prevent or plan future pregnancies, treatment facilities should elicit 
and respond carefully to the preferences of women before any intervention is implemented. 
 Because the survey was conducted at a facility where a majority of the women have some 
form of insurance, the responses about cost as a barrier to accessing contraception might be 
different compared to women who do not have insurance. In this study, 25.9% of women 
reported cost as a barrier to receiving a method of contraception of their choice. Interestingly, 
25.9% of women did not have insurance at the time of the survey. This study did not ask about 
sexual orientation, number of sexual partners, or knowledge of contraceptives; in previous 
literature these variables have been of interest. The participating 108 women constituted 49% of 
the population at one inpatient treatment facility in Nashville, Tennessee during the span of two 
months. As such, the preferences and experiences expressed by these women may not be an 
accurate representation of the population across the state, let alone the population across the 
country. However, the study sample does demographically represent the larger population of 
women in Tennessee who are currently accessing treatment for SUD and thus serves as a 
valuable source of information about the value of eliciting patient preferences as first step toward 
improving access to reproductive health for this population.  
Conclusion 
 Women in SUD treatment have unmet reproductive health needs. Of the approximately 
one-third of women who reported current use of contraception, 13% entered treatment with a 
LARC. However, 85% did not want to become pregnant in the next year. Women in this study 
voiced a strong preference for integrated contraception and SUD treatment, but a minority of 
NEEDS AMONG WOMEN WITH SUD 24 
women preferred separate care for SUD treatment and contraception. Integrating contraception 
with SUD treatment has shown to increase rates of effective contraceptive use, however the 
preferences of women should be considered before implementing any interventions. Future 
research should explore whether women prefer contraceptive counseling as a group or 
individually. This study highlights the importance of eliciting patient preference for service 
integration as well as responding to the expressed preferences of women by improving access to 
all methods of contraception.  
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 Figure 1. Social Cognitive Theory 
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Figure 2. Locations utilized for treatment of illness among women in inpatient treatment for 
substance use disorder in Nashville, TN (N=108). 
 
 
 
Figure 3. Locations utilized for Well Woman Exams among women in inpatient treatment for 
substance use disorder in Nashville, TN (N=108). 
 
33%
35%
32%
Sick Care Locations
Primary Care
Provider
Urgent
Care/Walk-In
Emergency
Department
63%
29%
4%
1% 3%
Well Woman Exam
Private Doctor's Office
Community/Public
Health Clinic
Planned Parenthood
Urgen care/Hospital
Never Received This
NEEDS AMONG WOMEN WITH SUD 34 
 
Figure 4. Locations utilized for STD screenings among women in inpatient treatment for 
substance use disorder in Nashville, TN (N=108). 
 
 
 
 
 
Figure 5. Locations utilized for obtaining a prescription or method for birth control among 
women in inpatient treatment for substance use disorder in Nashville, TN (N=108). 
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Tables 
 
Table 1. Sample demographics of women in inpatient treatment for substance use disorder in 
Nashville, TN (N=108).  
 
Characteristic n (%) 
Age (years) 
         19-29 
         30-40 
         41-51 
 
37 (34.3) 
59 (54.6) 
12 (11.1) 
Ethnicity 
         African American/Black 
         Hispanic/Latino 
         Caucasian/White 
         Native American/American Indian 
         Asian/Pacific Islander 
         Mixed Race 
 
18 (16.7) 
2 (1.9) 
80 (74.1) 
3 (2.8) 
1 (0.9) 
4 (3.7) 
Education 
         Some High School 
         High School or GED 
         Some College 
         2-year college degree 
         4-year college degree 
         Graduate or professional degree 
 
21 (19.4) 
50 (46.3) 
18 (16.7) 
12 (11.1) 
6 (5.6) 
1 (0.9) 
Marital Status 
          Single, never married 
          Married 
          Divorced or annulled 
          Separated, not divorced 
 
59 (54.6) 
17 (15.7) 
18 (16.7) 
14 (13) 
Insurance (Y/N) 
          Yes 
          No 
 
80 (74.1) 
28 (25.9) 
Insurance Type 
         Employer 
         Purchased Directly/Private 
         Medicaid/Government-assistance plan 
 
2 (1.9) 
4 (3.7) 
74 (68.5) 
 
 
Table 2. Access to health care providers and preferred locations for treatment of illnesses among 
women in inpatient treatment for substance use disorder in Nashville, TN (N=108). 
 
Access to Care n (%) 
Sick Care 
          Primary Care Provider 
          Urgent Care/Walk-In 
          Emergency Department 
 
36 (33.3) 
38 (35.1) 
34 (31.6) 
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Well Woman Exam 
          Private Doctor’s Office 
          Community/Public Health Clinic 
          Planned Parenthood Clinic 
          Urgent Care/Hospital 
          Never received this service 
 
68 (63) 
32 (29.6) 
4 (3.7) 
1 (0.9) 
3 (2.8) 
STD Screening 
          Private Doctor’s Office 
          Community/Public Health Clinic 
          Planned Parenthood Clinic 
          Urgent Care/Hospital 
          Never received this service 
 
51 (47.2) 
52 (48.1) 
3 (2.8) 
1 (0.9) 
1 (0.9) 
Prescription/Method of Birth Control 
          Private Doctor’s Office 
          Community/Public Health Clinic 
          Planned Parenthood Clinic 
          Urgent Care/Hospital 
          Never received this service 
 
58 (53.7) 
39 (36.1) 
3 (2.8) 
0 
8 (7.4) 
 
Table 3. Reproductive intent for the next year among women in inpatient treatment for substance 
use disorder in Nashville, TN (n=88). This question was not asked to 20 women who indicated 
tubal ligation or hysterectomy.  
 
Reproductive Intent n (%) 
    Would like to become pregnant 
    Do not want to become pregnant 
    Not sure 
    Okay either way 
6 (6.8) 
75 (85.2)  
1 (1.1) 
6 (6.8) 
 
 
Table 4a. Contraception utilization within the past year among women in inpatient treatment for 
substance use disorder in Nashville, TN (N=108).  
 
Methods of Contraception Yes [n (%)] No [n (%)] 
Oral Contraceptives 12 (11.1) 96 (88.9) 
Condoms 56 (51.9) 52 (48.1) 
Injectables  13 (12) 95 (88) 
Patch 1 (0.9) 107 (99.1) 
Intrauterine Devices (IUD) 9 (8.3) 99 (91.7) 
Implant 7 (6.5) 101 (93.5) 
Vaginal Ring 1 (0.9) 107 (99.1) 
Rhythm Method 3 (2.8) 105 (97.2) 
Emergency Contraception 6 (5.6) 102 (94.4) 
Withdrawal Method 23 (21.3) 85 (78.7) 
Tubal Ligation/Hysterectomy 20 (18.5) 88 (81.5) 
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Table 4b. Contraception utilization at the time of the survey among women in inpatient 
treatment for substance use disorder in Nashville, TN (n=88). This is a sub-sample after 
removing women with hysterectomies and tubal ligations. 
 
Contraception Utilization n (%) 
Current Contraception Use 
         Yes 
         No 
 
25 (28.4%) 
63 (71.6%) 
Method 
    Tier 1 
          IUD 
          Implant 
   Tier 2 
           Oral contraceptives 
           Injectables 
 
 
7 (7.9%) 
7 (7.9%) 
 
6 (6.8%) 
5 (5.6%) 
 
Table 5a. Payment methods for contraception in the past year (N=108). 
   
Payment Method 
       Private Insurance 
       Medicaid or government-assistance plan 
       Out-of-pocket payment 
       No payment necessary 
       Not applicable (Haven’t received birth         
                                control in past year) 
n (%) 
3 (2.8) 
42 (38.9) 
1 (0.9) 
5 (4.6) 
57 (52.8) 
 
 
Table 5b. Condom utilization in the past six months. 
 
Condom Utilization 
        Yes 
        No 
n (%) 
52 (48.1) 
56 (51.9) 
*Primary Purpose for use 
       STD Prevention 
       Pregnancy Prevention 
       Both 
 
18 (34.6) 
5 (9.6) 
29 (55.7) 
*Frequency of Use 
       Always 
       Most of the time 
       Sometimes 
 
12 (23) 
24 (46.2) 
16 (30.7) 
*Percentages reported as a sub-sample of 52 women who answered yes to using condoms. 
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Table 6. Preference for integration of birth control with substance use disorder treatment 
programs. 
 
Preferences for Integration n (%) 
Most Comfortable Talking About Birth 
Control With 
         Nurse Practitioners/Doctors 
         Nurses 
         Therapists 
         Case Managers 
 
 
25 (23.1) 
54 (50) 
25 (23.1) 
4 (3.7) 
Interest in Receiving Birth Control Before 
Discharge 
         Yes 
         No 
         Not Sure 
 
 
75 (69.4) 
30 (27.8) 
3 (2.8) 
Choice of Contraception if Provided Before 
Discharge 
    Tier 1 
          IUD 
          Implant 
    Tier 2 
          Oral Contraception 
          Injectables 
          Patch 
 None (I do not want any form) 
 
 
 
16 (14.8) 
15 (13.9) 
 
18 (16.7) 
24 (22.2) 
2 (1.8) 
33 (30.5) 
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Appendix 
Adapted survey 
Thank you so much for agreeing to participate in this women’s health and birth control survey. I 
really appreciate your time. Over the next few minutes I will be asking you some questions about 
to your personal health, the health care you receive, and some specific questions about birth 
control. When I say birth control I am referring to any way you would prevent pregnancy 
including pulling out, condoms, the pill, the shot, the patch, IUDs, implants. You do not have to 
answer the questions you don’t want to. Please stop me at any time if you have questions about 
what I say. I am happy to answer any questions and repeat any information. Everything we say 
during this session is confidential, including all of your answers and any personal information. 
At the end of this survey you will receive a candy bar and a resource packet. Are you ready to 
get started? 
 
I’d like to start off by asking you a few general questions about yourself. 
Section I: Demographics 
1. How old are you? (enter age in whole numbers) __________________ 
 
2. Please specify your ethnicity:  
 a. African American or Black 
 b. Hispanic or Latino 
 c. White 
 d. Native American or American Indian 
 e. Asian/Pacific Islander 
 f. Other: _____________________ 
 
3. What is the highest level of education you have completed? 
 a. Some high school 
 b. High school diploma  
 c. Some college credit, but did not graduate college 
 d. 2-year college degree 
 e. 4-year college degree 
 f. Graduate or professional school 
 
4. What is your marital status? 
 a. Single, never married 
 b. Married 
 c. Divorced or annulled 
 d. Separated, not divorced 
 e. Widowed 
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The next few questions will be about health care. 
Section II: Access to Care 
 
5. Do you currently have health insurance? 
 a. Yes 
 b. No 
 
6. What type of health insurance do you have? 
 a. Insurance through a current or former employer or union 
 b. Insurance purchased directly from an insurance company 
 c. Medicaid, Medical Assistance, or any kind of government-assistance plan for those  
  with low incomes or disabilities 
 d. TRICARE or other military health care 
 e. VA 
 
7. If you are sick, where do you go for care? 
 a. My primary care provider 
 b. Retail health clinic/walk-in clinic 
 c. Urgent Care 
 d. Emergency Department 
 e. Other: _______________ 
 
I am going to list off specific services that you may have received. Let me know where you 
received these services such as doctor’s office, planned parenthood, hospital/urgent care, etc. If 
you have not received a service, simply state “I have not received that service before”. 
 
8. For the following questions, please mark where you received each service. 
 
 a. Well-women exam 
  i. Private doctor's office/HMO 
  ii. Community or Public health clinic 
  iii. Family planning/Planned Parenthood clinic 
  iv. Urgent care/hospital 
  v. Never received these types of services 
 b. STD screening 
  i. Private doctor's office/HMO 
  ii. Community or Public health clinic 
  iii. Family planning/Planned Parenthood clinic 
  iv. Urgent care/hospital 
  v. Never received these types of services 
 c. Prescription for birth control or a method of birth control 
  i. Private doctor's office/HMO 
  ii. Community or Public health clinic 
  iii. Family planning/Planned Parenthood clinic 
  iv. Urgent care/hospital 
  v. Never received these types of services 
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Section III: Contraception Utilization 
 
I am going to show you a chart of different types of birth control methods. Please point at which 
methods you have used in the PAST YEAR- you can point at more than one method if you have 
used multiple methods in the past year. 
 
9. Have you used any of the following methods in the past year? (select yes or no) 
 a. Birth control pills or oral contraceptives (“the pill”) yes no 
 b. Male condoms      yes  no 
 c. Injectable birth control     yes no 
 d. Birth control patch (Ortho-Eva)    yes no 
 e. Intrauterine devices/IUD     yes no 
 f. Birth control implants     yes no 
 g. Vaginal ring (Nuva-ring)     yes no 
 h. Diaphragm, sponge, female condom, foam, cream yes no 
 i. Rhythm method/natural family planning   yes no 
 j. Sterilization (tubal ligation or hysterectomy)  yes no 
 k. Emergency contraception or “morning after pill”  yes no 
 l. Withdrawal or “pulling out” method   yes no 
 
10. Are you currently using any form of birth control? 
 a. Yes 
 b. No 
 
11. Specify which type of birth control you are currently on? 
 a. Birth control pills 
 b. Injectables (Depo-Provera) 
 c. Implant (Nexplanon/Implanon) 
 d. IUD 
 e. Vaginal ring 
 f. Patch 
 g. Tubal ligation (I’ve had my tubes “tied”) 
 h. Condoms 
 
Sometimes, different methods of birth control have different costs associated with them. 
 
12. Has cost ever been a barrier in obtaining the birth control of your choice? 
 a. Private insurance 
 b. Medicaid or other public insurance (TennCare) 
 c. Out-of-pocket payment 
 d. No payment necessary or copayment only 
 e. Not applicable (Haven’t received birth control in the past year) 
 
13. Have you used a condom in the past 6 months? 
 a. Yes 
 b. No 
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14. What is your primary purpose for using condoms? 
 a. STD prevention 
 b. Pregnancy prevention 
 c. Both 
 
15. How frequently do you use condoms? 
 a. Always 
 b. Most of the time 
 c. Sometimes 
 
Section IV: Reproductive Intent  
 
16. Would you like to become pregnant in the next year? 
 a. Yes 
 b. No 
 c. Not sure 
 d. Okay either way 
 
Section V: Preference for Integration  
 
17. Would you feel comfortable talking about birth control at The Next Door? 
 a. Yes 
 b. No 
 
18. Who would you feel most comfortable talking to? 
 a. Doctors 
 b. Nurse Practitioners 
 c. Pharmacists 
 d. Nurses 
 e. Therapists 
 f. Case Managers 
 
19. If we could provide you with a method of birth control of your choice before you leave, 
would you be interested? 
 a. Yes 
 b. No 
 c. Not sure 
 
20. If birth control were available at this location, and cost was not an issue, which method 
would you choose to use? 
 a. Oral birth control pills 
 b. IUS/IUS (intrauterine device) 
 c. Depo-Provera shot 
 d. Implant (Nexplanon) 
 e. None, I do not want any form of birth control 
 f. Other: ________________ 
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Women’s Health Survey  
 
 Are you a woman between 18 and 51 years of age? 
 Are you interested in voicing your thoughts on birth control and 
women’s health? 
 Do you want to be a part of a helpful research study? 
 
If you answered YES to any of these questions, you may be eligible to 
participate in an interview about birth control and family planning. 
 
The interview will take less than 10 minutes. To thank you for your time, 
you will receive a candy bar at the conclusion of the interview. No 
medications will be given. 
Where: Consult Room 2-2 (2nd floor) 
 
